Amicoumacin A induces cancer cell death by targeting the eukaryotic ribosome
- PMID: 27296282
- PMCID: PMC4906347
- DOI: 10.1038/srep27720
Amicoumacin A induces cancer cell death by targeting the eukaryotic ribosome
Abstract
Amicoumacin A is an antibiotic that was recently shown to target bacterial ribosomes. It affects translocation and provides an additional contact interface between the ribosomal RNA and mRNA. The binding site of amicoumacin A is formed by universally conserved nucleotides of rRNA. In this work, we showed that amicoumacin A inhibits translation in yeast and mammalian systems by affecting translation elongation. We determined the structure of the amicoumacin A complex with yeast ribosomes at a resolution of 3.1 Å. Toxicity measurement demonstrated that human cancer cell lines are more susceptible to the inhibition by this compound as compared to non-cancerous ones. This might be used as a starting point to develop amicoumacin A derivatives with clinical value.
Figures
References
-
- Wilson D. N. Ribosome-targeting antibiotics and mechanisms of bacterial resistance. Nature reviews. Microbiology 12, 35–48 (2014). - PubMed
-
- Pelletier J, P. S. W. In Translational control in biology and medicine (ed Sonenberg N. Mathews M. B., Hershey J. W. B.) 855–895 (2007).
-
- Itoh J. et al. Amicoumacin-A, a new antibiotic with strong antiinflammatory and antiulcer activity. The Journal of antibiotics 34, 611–613 (1981). - PubMed
-
- Itoh T. S. et al. Isolation, physicochemical properties and biological activities of amicoumacins produced by Bacillus pumilus. Agric. Biol. Chem. 46, 1255–1259 (1982).
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
